Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by tdon1229on Oct 11, 2020 1:27am

116 Views

Post# 31702048

RE:RE:RE:RE:RE:RE:RE:Big let down

Just utter stupidity ... if he's not BCG-unresponsive yet, then he can't participate in the Theralase trial per the exclusion criteria. Besides, he's in the US, the border is closed, there are no US trials yet, and it's not likely he would pass the screening criteria.
First, he'd have to be convinced himself, then find a doctor to treat him under the Right to Try rules. That doctor would have to be trained in the protocol, and Theralase would have to cooperate by providing the drug, the laser, and the computer backup.

At this time ,I'd put the probability somewhere around 0.000+.

Bullboard Posts

The top TSX healthcare stocks under $1